Brief: Allergy Therapeutics Sees H2 Sales Slightly Higher Than Previous Year
March 27 (Reuters) - Allergy Therapeutics PLC AGY.L :
* ALLERGY THERAPEUTICS PLC - IN SECOND HALF OF FINANCIAL
YEAR,
SALES ARE EXPECTED TO BE SLIGHTLY HIGHER THAN PREVIOUS YEAR
* ALLERGY THERAPEUTICS PLC - OVERALL SALES FOR FULL YEAR
ENDING ON
30 JUNE 2024 ARE EXPECTED TO BE SLIGHTLY LOWER THAN
CORRESPONDING PERIOD
Source text for Eikon: ID:nRSa4174Ia
Further company coverage: AGY.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Allergy Therapeutics
See all newsRCS - Allergy Therapeutics - Allergy Therapeutics to present at EAACI 2026
UK's Allergy Therapeutics H1 revenue rises 7%, operating loss widens
Brief: Allergy Therapeutics H1 Pretax Profit GBP -19.33 Million
Allergy Therapeutics - Interim Results for six months ended 31 Dec 2025
Allergy Therapeutics - PDMR Dealings & Shareholding Update